Bioavailability of EPA and DHA delivered by gelled emulsions and soft gel capsules

European Journal of Lipid Science and Technology

Volumn 113, Issue 2, 2011, Pages 137-145

  Haug, Ingvild J ^a   Sagmo, Lise B ^b   Zeiss, Daniel ^b   Olsen, Inge C ^c   Draget, Kurt I ^a   Seternes, Tore ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORD UNIVERSITY   (Norway)

^c Smerud Medical Research International AS   (Norway)

^d Ayanda AS   (Norway)

Author keywords

Bioavailability; DHA; Emulsion; EPA; Fatty acid

Indexed keywords

EID: 79551712499     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201000450     Document Type: Article

References (36)

1. Cao, J., Schwichtenberg, K. A., Hanson, N. Q., Tsai, M. Y., Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin. Chem. 2006, 52, 2265- 2272.
2. Marangoni, F., Angeli, M. T., Colli, S., Eligini, S., et al., Changes of N-3 and N-6 fatty-acids in plasma and circulating cells of normal subjects, after prolonged administration of 20/5 (EPA) and 22/6 (DHA) ethyl-esters and prolonged washout. Biochim. Biophys. Acta 1993, 1210, 55- 62.
3. Marsen, T. A., Pollok, M., Oette, K., Baldamus, C. A., Pharmacokinetics of omega-3-fatty-acids during ingestion of fish oil preparations. Prostaglandins, Leukotrienes Essent. Fatty Acids 1992, 46, 191- 196.
4. Vidgren, H. M., Agren, J. J., Schwab, U., Rissanen, T., et al., Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997, 32, 697- 705.
5. Bucher, H. C., Hengstler, P., Schindler, C., Meier, G., N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials. Am. J. Med. 2002, 112, 298- 304.
6. Tavazzi, L., Maggioni, A. P., Marchioli, R., Barlera, S., et al., Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008, 372, 1223- 1230.
7. Wang, C. C., Harris, W. S., Chung, M., Lichtenstein, A. H., et al., n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am. J. Clin. Nutr. 2006, 84, 5- 17.
8. Brunborg, L. A., Madland, T. M., Lind, R. A., Arslan, G., et al., Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clin. Nutr. 2008, 27, 614- 622.
9. Goldberg, R. J., Katz, J., A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129, 210- 223.
10. Raz, R., Gabis, L., Essential fatty acids and attention-deficit-hyperactivity disorder: A systematic review. Dev. Med. Child Neurol. 2009, 51, 580- 592.
11. Schuchardt, J. P., Huss, M., Stauss-Grabo, M., Hahn, A., Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur. J. Pediatr. 2010, 169, 149- 164.
12. Golding, M., Wooster, T. J., The influence of emulsion structure and stability on lipid digestion. Curr. Opin. Colloid Interface Sci. 2010, 15, 90- 101.
13. Mcclements, D. J., Decker, E. A., Park, Y., Controlling lipid bioavailability through physicochemical and structural approaches. Crit. Rev. Food Sci. Nutr. 2009, 49, 48- 67.
14. Raatz, S. K., Redmon, J. B., Wimmergren, N., Donadio, J. V., Bibus, D. M., Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil. J. Am. Diet. Assoc. 2009, 109, 1076- 1081.
15. Lundin, L., Golding, M., Structure design for healthy food. Aust. J. Dairy Technol. 2009, 64, 68- 74.
16. Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., Schmidt, E. B., Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes Essent. Fatty Acids 2010, 83, 137- 141.
17. Klinkesorn, U., McClements, D. J., Influence of chitosan on stability and lipase digestibility of lecithin-stabilized tuna oil-in-water emulsions. Food Chem. 2009, 114, 1308- 1315.
18. Armand, M., Borel, P., Dubois, C., Senft, M., et al., Characterization of emulsions and lipolysis of dietary lipids in the human stomach. Am. J. Physiol. 1994, 266, G372- G381.
19. Armand, M., Borel, P., Pasquier, B., Dubois, C., et al., Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am. J. Physiol. Gastrointest. Liver Physiol. 1996, 34, G172- G183.
20. Armand, M., Pasquier, B., Andre, M., Borel, P., et al., Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am. J. Clin. Nutr. 1999, 70, 1096- 1106.
21. Garaiova, I., Guschina, I. A., Plummer, S. F., Tang, J., et al., A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr. J. 2007, 6, 4.
22. Haug, I. J., Draget, K. I., WO2007/085840, 2007.
23. EMEA., Note for Guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98 London: The European Agency for the Evaluation of Medicinal Products, 2001.
24. Hsu, J. C., The factor analytic approach to simultaneous inference in the general linear model. J. Comput. Graph. Stat. 1992, 1, 151- 168.
25. McDowell, E. M., Trump, B. F., Histologic fixatives suitable for diagnostic light and electron microscopy. Arch. Pathol. Lab. Med. 1976, 100, 405- 414.
26. European Directorate for the Quality of Medicines & HealthCare: European Pharmacopoeia Strasbourg Cedex, France, 2008.
27. Elvevoll, E. O., Barstad, H., Breimo, E. S., Brox, J., et al., Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 2006, 41, 1109- 1114.
28. Schram, L. B., Nielsen, C. J., Porsgaard, T., Nielsen, N. S., et al., Food matrices affect the bioavailability of (n-3) polyunsaturated fatty acids in a single meal study in humans. Food Res. Int. 2007, 40, 1062- 1068.
29. Borel, P., Pasquier, B., Armand, M., Tyssandier, V., et al., Processing of vitamin A and E in the human gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280, G95- G103.
30. Barrow, C. J., Nolan, C., Holub, B. J., Bioequivalence of encapsulated and microencapsulated fish-oil supplementation. J. Funct. Foods 2009, 1, 38- 43.
31. Arterburn, L. M., Hall, E. B., Oken, H., Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J. Clin. Nutr. 2006, 83, 1467S- 1476S.
32. Arterburn, L. M., Oken, H. A., Hoffman, J. P., Bailey-Hall, E., et al., Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids 2007, 42, 1011- 1024.
33. Lund, E. K., Harvey, L. J., Ladha, S., Clark, D. C., Johnson, I. T., Effects of dietary fish oil supplementation on the phospholipid composition and fluidity of cell membranes from human volunteers. Ann. Nutr. Metab. 1999, 43, 290- 300.
34. Golding, M., Wooster, T. J., Day, L., Lundin, L., et al., Impact of gastric structuring on the lipolysis of emulsified lipids. in preparation.
35. Klinkesorn, U., McClements, D. J., Impact of lipase, bile salts, and polysaccharides on properties and digestibility of tuna oil multilayer emulsions stabilized by lecithin-chitosan. Food Biophys. 2010, 5, 73- 81.
36. Rusca, A., Di Stefano, A. F. D., Doig, M. V., Scarsi, C., Perucca, E., Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur. J. Clin. Pharmacol. 2009, 65, 503- 510.